CS MEDICA Announces Indian State’s FDA Approval for Two Cosmetic Products
CS MEDICA is thrilled to announce that the Indian State’s FDA has granted official approval for two cosmetic products to be marketed and sold through its subsidiary, CANNORDIC India Ltd.CS MEDICA A/S (“CS MEDICA” or “The Company”), a global MedTech company specializing in CBD and pain management, is pleased to announce a significant achievement in its Global expansion. After rigorous scrutiny, the Indian State’s FDA has granted approval for two cosmetic products with CBD from CS MEDICA, the CANNASEN[®] Anti-Hair Loss Serum and CANNASEN[®] PSOR+Atopic Lotion. Kamlesh Vora, Managing